Scientis

Cyspera operates in the dermatological sector, focusing on providing advanced solutions for hyperpigmentation. The company offers Cyspera Intensive Pigment Corrector, a product designed to address pigmentation concerns such as melasma and lentigo simplex. This product is available exclusively through dispensing clinics, ensuring professional oversight and application. Cyspera's business model revolves around partnerships with certified dermatologists and healthcare professionals, who recommend and distribute their products to clients seeking effective skin tone correction. The company generates revenue through these clinic-based sales, targeting individuals with pigmentation issues who are looking for clinically validated treatments. Cyspera's market is primarily composed of individuals experiencing hyperpigmentation, a condition characterized by darker skin patches due to excess melanin. The company's approach emphasizes safety and efficacy, with a focus on delivering visible results without adverse side effects.

Keywords: hyperpigmentation, dermatology, pigment correction, melasma, lentigo simplex, skin tone, clinics, dermatologists, healthcare, melanin.